Table 1. Patient characteristics for the MF and RS groups.
MF (n = 305) | RS (n = 72) | Statistical significance | |
---|---|---|---|
Age (y, mean [SD]) | 48.9 (10.4) | 47.4 (10.7) | NS |
Sex (% male) | 51.8% | 40.3% | NS (p ≤ 0.089) |
Ear (% right) | 45.2% | 48.6% | NS |
Tumor size (cm, mean [SD]) | 1.0 (0.36) | 1. 8 (0.38) | p ≤ 0.001 |
Duration Sx (mo, mean [SD]) | 18.1 (30.0) | 18.0 (28.46) | NS |
Presenting symptoms | |||
Hearing loss | 83.9% | 75.0% | NS (p ≤ 0.09) |
Dizzy | 41.0% | 25.0% | 0.015 |
Tinnitus | 77.0% | 73.6% | NS |
Headache | 16.7% | 27.8% | p ≤ 0.043 |
Paresthesia | 0.7% | 2.8% | NS |
Abbreviations: MF, middle fossa; NS, not significant; RS, retrosigmoid; SD, standard deviation; Sx, symptoms.